Bank Of America Corp Genfit S.A. Transaction History
Bank Of America Corp
- $1.21 Trillion
- Q1 2025
A detailed history of Bank Of America Corp transactions in Genfit S.A. stock. As of the latest transaction made, Bank Of America Corp holds 17 shares of GNFT stock, worth $69. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17Holding current value
$69% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding GNFT
# of Institutions
9Shares Held
209KCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny131KShares$540,3950.0% of portfolio
-
Morgan Stanley New York, NY25.5KShares$104,8870.0% of portfolio
-
Old Mission Capital LLC22.2KShares$91,3980.0% of portfolio
-
Optiver Holding B.V. Amsterdam, P713.2KShares$54,0670.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.3KShares$50,6800.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $205M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...